Cyclic sulfonamide ribonucleotide reductase (RNR) inhibitors and uses thereof

Provided herein are compounds and methods for the treatment of cancer. The methods include administering to a subject in need a therapeutically effective amount of a cyclic sulfonamide RNR inhibitor disclosed herein.

Saved in:
Bibliographic Details
Main Authors ELSDON, RACHELLE JANETTE, TRUONG, YEN PHAM HONG, MAUGER, JACQUES, MEYER, STEPHEN TODD, PINKERTON, ANTHONY B
Format Patent
LanguageChinese
English
Published 16.07.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided herein are compounds and methods for the treatment of cancer. The methods include administering to a subject in need a therapeutically effective amount of a cyclic sulfonamide RNR inhibitor disclosed herein.
Bibliography:Application Number: TW202211134951